NICM
CVS icon

Neo Ivy Capital Management’s CVS Health CVS Stock Holding History

Neo Ivy Capital Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-11,290
Closed -$811K – 396
2026
Q1 		$811K Buy
+11,290
New +$870K 0.21% 158
2025
Q4 		– Sell
-10,626
Closed -$801K – 383
2025
Q3 		$801K Buy
10,626
+9,372
+747% +$642K 0.2% 170
2025
Q2 		$86.5K Buy
+1,254
New +$82.2K 0.03% 302
2024
Q3 		– Sell
-13,596
Closed -$803K – 297
2024
Q2 		$803K Buy
+13,596
New +$850K 0.16% 156
2023
Q4 		– Sell
-4,160
Closed -$290K – 329
2023
Q3 		$290K Sell
4,160
-45,601
-92% -$3.23M 0.13% 205
2023
Q2 		$3.44M Buy
+49,761
New +$3.54M 1.81% 4
2022
Q4 		– Sell
-1,248
Closed -$119K – 384
2022
Q3 		$119K Sell
1,248
-2,640
-68% -$261K 0.31% 123
2022
Q2 		$360K Sell
3,888
-1,620
-29% -$158K 0.96% 2
2022
Q1 		$558K Buy
+5,508
New +$579K 0.5% 48
2021
Q4 		– Sell
-2,554
Closed -$166K – 470
2021
Q3 		$166K Sell
2,554
-672
-21% -$56.3K 0.19% 175
2021
Q2 		$269K Buy
3,226
+2,900
+890% +$237K 0.27% 138
2021
Q1 		$25K Sell
326
-12,561
-97% -$915K 0.03% 385
2020
Q4 		$880K Sell
12,887
-2,195
-15% -$143K 0.98% 4
2020
Q3 		$880K Buy
15,082
+12,528
+491% +$780K 0.89% 4
2020
Q2 		$166K Buy
2,554
+2,207
+636% +$139K 0.19% 175
2020
Q1 		$21K Sell
347
-9,097
-96% -$607K 0.03% 374
2019
Q4 		$702K Buy
9,444
+9,354
+10,393% +$657K 0.81% 9
2019
Q3 		$5K Buy
+90
New +$5.33K ﹤0.01% 264
2019
Q1 		– Sell
-17,192
Closed -$1.13M – 306
2018
Q4 		$1.13M Buy
+17,192
New +$1.28M 0.89% 11

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Neo Ivy Capital Management's CVS Position: Q2 2026 in Review

Neo Ivy Capital Management sold out of CVS Health (CVS) in Q2 2026, closing a stake of 11,290 shares — an estimated $811K sold.

Neo Ivy Capital Management first reported a position in CVS in Q4 2018 and held it in 19 quarters. The position peaked at $3.44M in Q2 2023. 2,073 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Neo Ivy Capital Management reported no remaining CVS Health position as of Q2 2026 after selling out during the quarter.
  • Neo Ivy Capital Management sold 11,290 CVS Health shares in Q2 2026, an estimated $811K.
  • Neo Ivy Capital Management first reported a position in CVS Health in Q4 2018 and held it in 19 quarters.
  • Neo Ivy Capital Management's CVS Health position peaked at $3.44M in Q2 2023.
  • 2,073 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Neo Ivy Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.